RxDoctor Payments Data

Shital Mehta, MD

Psychiatry · Kankakee, ILNPI 1205054608

Payments from drug & device makers

$6,440in general payments, 2019–2025

Across 228 payments — averaging $28.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Sunovion Pharmaceuticals Inc.$295
  • Axsome Therapeutics, Inc.$200
  • Alkermes, Inc.$166
  • Biogen$163
  • Otsuka America Pharmaceutical, Inc.$123
  • plus $837 from 16 others

What the payments were for

  • Consulting fees$2,10033%
  • Travel & lodging$1,16918%
  • Food & beverage$2,99246%
  • Education$1793%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,440 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$72,153
Medicare patients
182
Services billed
700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl125$182,616
Invega TrinzaPaliperidone Palmitate11$85,282
RexultiBrexpiprazole21$32,537
TrintellixVortioxetine Hydrobromide29$23,539
Lurasidone Hcl16$7,983
VyvanseLisdexamfetamine Dimesylate12$4,654
Hydroxyzine Hcl240$4,553
Venlafaxine Hcl ErVenlafaxine Hcl154$3,459
Quetiapine Fumarate227$3,078
Duloxetine Hcl185$3,053
Aripiprazole61$2,988
Trazodone Hcl273$2,579
Buspirone Hcl150$2,458
Atomoxetine Hcl21$2,323
Bupropion XlBupropion Hcl131$2,218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$4,656$182,616125 claims
Johnson & JohnsonInvega Trinza$102$85,28211 claims
Otsuka America Pharmaceutical, Inc.Rexulti$123$32,53721 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$36$28,19441 claims
Almatica Pharma LLCSertraline Hcl$29$1,536159 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Kankakee

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →